Valuation: CeriBell, Inc.

Market Cap 736M 643M 595M 546M 1.03B 70.93B 1.05B 7.1B 2.79B 34.64B 2.76B 2.7B 120B P/E 2026 *
-11.4x
P/E 2027 * -16.9x
Enterprise Value 723M 632M 584M 536M 1.01B 69.65B 1.03B 6.97B 2.74B 34.01B 2.71B 2.65B 117B EV / Sales 2026 *
6.34x
EV / Sales 2027 * 4.88x
Free-Float
87.21%
Yield 2026 *
-
Yield 2027 * -
1 day-1.34%
1 week-1.34%
Current month-1.59%
1 month+2.96%
3 months-6.77%
6 months-16.20%
Current year-12.72%
1 week 18.49
Extreme 18.49
20.24
1 month 17.07
Extreme 17.07
20.76
Current year 15.84
Extreme 15.84
24.33
1 year 10.85
Extreme 10.85
24.33
3 years 10.01
Extreme 10.01
32.75
5 years 10.01
Extreme 10.01
32.75
10 years 10.01
Extreme 10.01
32.75
Manager TitleAgeSince
Chief Executive Officer 46 2015-09-30
Director of Finance/CFO 44 2020-03-31
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 46 2014-08-28
Chairman 57 2014-08-28
Director/Board Member 64 2021-03-31
Date Insider Type Main position Quantity % Market Cap.
7/7/26 Sell

Founder

-89,000 0.2346%
6/30/26 Sell

Director

-2,207 0.0058%
6/26/26
TPG Group Holdings (SBS) Advisors, Inc.
SellCompany -202,368 0.5334%
Change 5-day change 1-year change 3-year change Capi.($)
-1.34%-1.34%+21.68% - 736M
+1.85%-7.97%-13.87%+14.73% 3.72B
-2.58%-10.52%+47.21% - 1.44B
+0.62%+0.10%+63.04%+71.65% 120M
-5.63%-16.77%0.00%-5.63% 64.26M
Average -1.28%-6.99%+23.61%+26.92% 1.22B
Weighted average by Cap. +0.32%-8.06%+6.58%+16.14%

Financials

2026 *2027 *
Net sales 114M 99.64M 92.15M 84.56M 160M 10.98B 163M 1.1B 432M 5.36B 428M 419M 18.52B 146M 127M 118M 108M 205M 14.05B 208M 1.41B 552M 6.86B 548M 536M 23.7B
Net income -65.38M -57.15M -52.85M -48.5M -91.79M -6.3B -93.39M -630M -248M -3.08B -246M -240M -10.62B -44.3M -38.72M -35.81M -32.86M -62.19M -4.27B -63.27M -427M -168M -2.08B -166M -163M -7.2B
Net Debt -13.26M -11.59M -10.72M -9.84M -18.61M -1.28B -18.94M -128M -50.21M -624M -49.79M -48.7M -2.15B -24.76M -21.65M -20.02M -18.37M -34.77M -2.39B -35.37M -239M -93.78M -1.17B -93M -90.96M -4.02B
Logo CeriBell, Inc.
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its hardware is composed of disposable, flexible headbands and head caps (Wearables) and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals. EEG data captured by the recorder are interpreted by its proprietary AI-powered seizure detection algorithms, which monitor the patient’s EEG signal and support the clinician’s real-time assessment of seizure activity.
Employees
327
Date Price Change Volume
26-07-16 US$19.14 -1.34% 530,924
26-07-15 US$19.40 +1.41% 290,777
26-07-14 US$19.13 -2.00% 387,150
26-07-13 US$19.52 -0.20% 268,428
26-07-10 US$19.56 -0.41% 197,195
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
19.40USD
Average target price
26.86USD
Spread / Average Target
+38.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CBLL Stock